HIGHLIGHTS
- who: Luis Jaramillo-Valverde et al. from the Laboratorio de Biotecnologu00eda y Biologu00eda Molecular, Instituto Nacional de Salud, Lima, Peru School of Medicine, Universidad Continental, Lima, Peru have published the Article: GSTT1/GSTM1 Genotype and Anti-Tuberculosis Drug-Induced Hepatotoxicity in Peruvian Patients, in the Journal: (JOURNAL) of 20/09/2022
- what: The authors propose that the presence of the present genotype null genotype fast NAT2 acetylators and CYP2E1 c1/c1 genotype in the Peruvian population could be considered a risk factor for the development of ADR due to therapeutic drug intake. The aim of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.